Dr. Todd Cohen and the efforts of the Cohen Lab were mentioned in the Oshkosh Herald!  The story below features the efforts of Gary Beyer, a patient with sporadic Inclusion Body Myositis (sIBM), a muscle weakening disease that is similar in molecular origin to Amyotropic Lateral Sclerosis (ALS).

The article also mentions a Podcast Conversation with Dr. Todd Cohen on similar subjects

To read the full story, click the pdf link below!

Click here to download- Oshkosh Newsletter page 3

Check us out on YouTube!

 TDP-43 mediated neurodegeneration in Amyotrophic Lateral Sclerosis (ALS) 

Like tau acetylation and phosphorylation in Alzheimer’s Disease, TDP-43 modifications similarly promote aberrant pathology seen in diseased brain and spinal cord of ALS and FTLD-TDP patients. Understanding such post-translational mechanisms could lead to better therapeutic avenues to pursue for ALS, FTD and other diseases characterized by TDP-43 pathology.